NO20083784L - Nytt sitratsalt av en indol derivativ og den farmasoytiske bruken derav - Google Patents

Nytt sitratsalt av en indol derivativ og den farmasoytiske bruken derav

Info

Publication number: NO20083784L
Authority: NO; Norway
Prior art keywords: pharmaceutical use; citrate salt; indole derivative; salt; fresh citrate
Prior art date: 2006-02-02

Application number

NO20083784A

Other languages

English (en)

Norwegian (no)

Inventor

Anna-Lena Berg

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-02

Filing date

2008-09-02

Publication date

2008-10-13

2008-09-02 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2008-10-13 Publication of NO20083784L publication Critical patent/NO20083784L/no

Links

150000001860 citric acid derivatives Chemical class 0.000 title 1
150000002475 indoles Chemical class 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
102000001267 GSK3 Human genes 0.000 abstract 1
108060006662 GSK3 Proteins 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
-1 salt 2-hydroxy-3- [5- (morpholin-4-ylmethyl) pyridin-2-yl] 1H-indole-5-carbonitrile citrate Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20083784A 2006-02-02 2008-09-02 Nytt sitratsalt av en indol derivativ og den farmasoytiske bruken derav NO20083784L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US76455106P	2006-02-02	2006-02-02
PCT/SE2007/000086 WO2007089191A1 (en)	2006-02-02	2007-01-31	New citrate salt of an indole derivative and its pharmaceutical use

Publications (1)

Publication Number	Publication Date
NO20083784L true NO20083784L (no)	2008-10-13

Family

ID=38327680

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20083784A NO20083784L (no)	2006-02-02	2008-09-02	Nytt sitratsalt av en indol derivativ og den farmasoytiske bruken derav

Country Status (24)

Country	Link
US (2)	US8008294B2 (pt)
EP (1)	EP1981869A4 (pt)
JP (1)	JP2009525324A (pt)
KR (1)	KR20080098022A (pt)
CN (2)	CN101379053A (pt)
AR (1)	AR059225A1 (pt)
AU (1)	AU2007210336B2 (pt)
BR (1)	BRPI0706745A2 (pt)
CA (1)	CA2641900A1 (pt)
EC (1)	ECSP088647A (pt)
IL (1)	IL192888A0 (pt)
MX (1)	MX2008009719A (pt)
MY (1)	MY146102A (pt)
NO (1)	NO20083784L (pt)
NZ (1)	NZ570849A (pt)
PE (1)	PE20090192A1 (pt)
RU (1)	RU2415137C2 (pt)
SA (1)	SA07280004B1 (pt)
SG (1)	SG169381A1 (pt)
TW (1)	TW200800977A (pt)
UA (1)	UA94251C2 (pt)
UY (1)	UY30126A1 (pt)
WO (1)	WO2007089191A1 (pt)
ZA (1)	ZA200806725B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SA07280004B1 (ar) *	2006-02-02	2011-10-29	استرازينيكا ايه بي	ملح سترات من مركب 2- هيدروكسي –3- [5- (مورفولين –4- يل ميثيل) بيريدين –2- يل] 1h- إندول –5- كربونيتريل سترات
BRPI0810216A2 (pt) *	2007-04-18	2014-10-21	Astrazeneca Ab	Processo para a preparação de composto, composto, e, método de tratamento de distúrbio bipolar
WO2009017452A1 (en) *	2007-07-30	2009-02-05	Astrazeneca Ab	New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate
US20100189791A1 (en)	2009-01-23	2010-07-29	Teva Pharmaceutical Industries, Ltd.	Delayed release rasagiline malate formulation
EP3920885A1 (en)	2019-02-08	2021-12-15	Frequency Therapeutics, Inc.	Valproic acid compounds and wnt agonists for treating ear disorders
TW202204348A (zh) *	2020-04-07	2022-02-01	美商西爾拉癌症醫學公司	Ｃｈｋ１抑制劑之合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100785109B1 (ko)	2001-04-05	2007-12-12	토렌트 파마슈티칼스 리미티드	노화 관련 및 당뇨병 혈관성 합병증에 사용되는 헤테로사이클릭 화합물
JP2003009588A (ja)	2001-06-20	2003-01-10	Toshiba Corp	車両連続運転装置用インバータ装置
SE0200979D0 (sv) *	2002-03-28	2002-03-28	Astrazeneca Ab	New compounds
SE0302546D0 (sv) *	2003-09-24	2003-09-24	Astrazeneca Ab	New compounds
JP2007502300A (ja) *	2003-08-13	2007-02-08	カイロン　コーポレイション	Ｇｓｋ−３インヒビターおよびその使用
KR101334511B1 (ko)	2004-12-30	2013-11-29	아스텍스 테라퓨틱스 리미티드	Ｃｄｋ, ｇｓｋ 및 오로라 키나아제의 활성을 조절하는피라졸 화합물
SA07280004B1 (ar)	2006-02-02	2011-10-29	استرازينيكا ايه بي	ملح سترات من مركب 2- هيدروكسي –3- [5- (مورفولين –4- يل ميثيل) بيريدين –2- يل] 1h- إندول –5- كربونيتريل سترات

2007
- 2007-01-23 SA SA07280004A patent/SA07280004B1/ar unknown
- 2007-01-29 TW TW096103245A patent/TW200800977A/zh unknown
- 2007-01-29 AR ARP070100366A patent/AR059225A1/es not_active Application Discontinuation
- 2007-01-31 MX MX2008009719A patent/MX2008009719A/es active IP Right Grant
- 2007-01-31 CA CA002641900A patent/CA2641900A1/en not_active Abandoned
- 2007-01-31 MY MYPI20082900A patent/MY146102A/en unknown
- 2007-01-31 UA UAA200809265A patent/UA94251C2/ru unknown
- 2007-01-31 CN CNA2007800041531A patent/CN101379053A/zh active Pending
- 2007-01-31 UY UY30126A patent/UY30126A1/es not_active Application Discontinuation
- 2007-01-31 US US12/162,540 patent/US8008294B2/en not_active Expired - Fee Related
- 2007-01-31 CN CNA2007800043630A patent/CN101378754A/zh active Pending
- 2007-01-31 NZ NZ570849A patent/NZ570849A/en not_active IP Right Cessation
- 2007-01-31 EP EP07709302A patent/EP1981869A4/en not_active Withdrawn
- 2007-01-31 AU AU2007210336A patent/AU2007210336B2/en not_active Ceased
- 2007-01-31 SG SG201100793-7A patent/SG169381A1/en unknown
- 2007-01-31 WO PCT/SE2007/000086 patent/WO2007089191A1/en not_active Ceased
- 2007-01-31 JP JP2008553201A patent/JP2009525324A/ja not_active Ceased
- 2007-01-31 KR KR1020087019047A patent/KR20080098022A/ko not_active Ceased
- 2007-01-31 RU RU2008131906/04A patent/RU2415137C2/ru not_active IP Right Cessation
- 2007-01-31 BR BRPI0706745-3A patent/BRPI0706745A2/pt not_active IP Right Cessation
- 2007-02-02 US US11/670,681 patent/US20070203137A1/en not_active Abandoned
- 2007-08-02 PE PE2007001013A patent/PE20090192A1/es not_active Application Discontinuation
2008
- 2008-07-17 IL IL192888A patent/IL192888A0/en unknown
- 2008-07-24 EC EC2008008647A patent/ECSP088647A/es unknown
- 2008-08-01 ZA ZA200806725A patent/ZA200806725B/xx unknown
- 2008-09-02 NO NO20083784A patent/NO20083784L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2007210336B2 (en)	2011-03-24
UA94251C2 (ru)	2011-04-26
RU2415137C2 (ru)	2011-03-27
MX2008009719A (es)	2008-09-04
AU2007210336A1 (en)	2007-08-09
TW200800977A (en)	2008-01-01
ECSP088647A (es)	2008-08-29
SA07280004B1 (ar)	2011-10-29
ZA200806725B (en)	2009-07-29
CN101379053A (zh)	2009-03-04
CN101378754A (zh)	2009-03-04
WO2007089191A1 (en)	2007-08-09
BRPI0706745A2 (pt)	2011-04-05
SG169381A1 (en)	2011-03-30
PE20090192A1 (es)	2009-03-20
CA2641900A1 (en)	2007-08-09
KR20080098022A (ko)	2008-11-06
US20070203137A1 (en)	2007-08-30
US20090023732A1 (en)	2009-01-22
EP1981869A1 (en)	2008-10-22
MY146102A (en)	2012-06-29
US8008294B2 (en)	2011-08-30
UY30126A1 (es)	2007-09-28
NZ570849A (en)	2011-01-28
JP2009525324A (ja)	2009-07-09
EP1981869A4 (en)	2010-08-25
IL192888A0 (en)	2009-02-11
RU2008131906A (ru)	2010-03-10
AR059225A1 (es)	2008-03-19

Legal Events

Date	Code	Title	Description
2013-08-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
EA200970595A1 (ru)	2010-02-26	Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA201070167A1 (ru)	2013-07-30	Замещенные производные индазола, активные как ингибиторы киназы
CY1117667T1 (el)	2017-05-17	3,4-διαρυλπυραζολια ως αναστολεις κινασης πρωτεϊνης
EP4512484A3 (en)	2025-05-07	Excipients for nicotine-containing therapeutic compositions
NO20073959L (no)	2007-09-27	Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
CY1118819T1 (el)	2018-01-10	Ετεροκυκλικες ενωσεις αγωνιστες του υποδοχεα ip
EA200970611A1 (ru)	2009-12-30	Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
EA200870373A1 (ru)	2009-04-28	Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ
ATE470443T1 (de)	2010-06-15	Indol-1-yl-essigsäurederivate
NO20075136L (no)	2007-12-07	Nye liposompreparater
ATE514699T1 (de)	2011-07-15	Substituierte pyrrolopyrazolderivate als kinaseinhibitoren
NO20061506L (no)	2006-06-02	Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
EP2178870A4 (en)	2012-04-11	INDOL AND INDAZONE COMPOUNDS AS AN INHIBITORS OF CELL NECROSIS
NO20081942L (no)	2008-04-23	Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
JOP20240037A1 (ar)	2024-02-20	مركبات الإندول وطرق الاستخدام
WO2006047032A3 (en)	2006-10-12	Indole compounds useful as serotonin selective agents
BR112014009910A2 (pt)	2017-04-25	formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico
NO20073854L (no)	2007-11-13	Doseringsform og fremgangsmate for vedvarende frigjoring av en substituert pyrazinforbindelse
NO20074933L (no)	2007-09-28	Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
EA200601901A1 (ru)	2007-04-27	Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием
SG169381A1 (en)	2011-03-30	New citrate salt of an indole derivative and its pharmaceutical use
NO20092067L (no)	2009-09-04	5-(heterosyklyl)alkyl-n- (arylsulfonyl)indolforbindelserog deres anvendelse som 5-HT6-ligander
ATE399156T1 (de)	2008-07-15	Neue indol- oder benzimidazol-derivate
ATE444069T1 (de)	2009-10-15	Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen
EA200970122A1 (ru)	2009-06-30	Фармацевтически приемлемые солевые и полиморфные формы малеата флюпиртина